Hypertrophic Cardiomyopathy Program in Milwaukee, Wis.
Hypertrophic cardiomyopathy (HCM) is a genetic disease that causes a thickening, or hypertrophy, of the heart muscle, limiting the heart’s ability to function properly. HCM can cause heart valve problems, chest pain, dizziness and shortness of breath, and is the most common cause of sudden cardiac death in people under age 30.
Specialized, multidisciplinary care is needed to expertly diagnose the condition, assess risks and develop effective treatment approaches.
Expert HCM Care, Including Septal Myectomy
Since hypertrophic cardiomyopathy is a multifaceted genetic and cardiac condition, it is best treated by physicians and staff specially trained to manage it properly and highly experienced in doing so. This is especially true for people diagnosed with HCM who may be contemplating pregnancy, scheduling non-cardiac surgery or facing other health events that need careful cardiac management.
Consider these advantages available when choosing HCM care at Froedtert & the Medical College of Wisconsin:
- Care is provided by board-certified cardiologists with extensive specialized training (fellowship and post-fellowship) in the treatment of HCM and adult congenital heart conditions. Find an HCM specialist.
- These physicians are backed by a multidisciplinary team of specialists in valve disease, electrical problems in the heart (electrophysiology), genetic counseling, lung disease (pulmonology), interventional cardiology and heart and vascular surgery.
- Because this is a genetic disease, the team collaborates with Children’s Hospital of Wisconsin and pediatric cardiologists for screenings and evaluations of young family members.
- Our approach to treatment is cutting-edge, based on proven and evidence-based protocols, focused on reducing risk and alleviating symptoms.
- These treatments include septal myectomy, a very intricate open heart surgery not offered everywhere and that requires experienced surgeons such as those at Froedtert & the Medical College of Wisconsin.
- We offer the latest technology for comprehensive diagnostic and treatment options.
- Research, both onsite and through collaborative opportunities with national genetics and cardiovascular centers, offers patients access to best practice approaches as soon as available.